Marc Shuman

1.4k total citations
20 papers, 1.1k citations indexed

About

Marc Shuman is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Shuman has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Shuman's work include Glioma Diagnosis and Treatment (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Inflammatory mediators and NSAID effects (3 papers). Marc Shuman is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Inflammatory mediators and NSAID effects (3 papers). Marc Shuman collaborates with scholars based in United States, Sweden and Denmark. Marc Shuman's co-authors include James L. Rubenstein, O.O. Melnyk, M B Zimmerman, Chris Haqq, Arthur Shen, Michael D. Prados, Jon Karch, Jane Fridlyand, Michael McDermott and Long-Cheng Li and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Marc Shuman

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Shuman United States 11 396 329 317 259 257 20 1.1k
Katrin M. Carlson United States 10 716 1.8× 244 0.7× 224 0.7× 69 0.3× 160 0.6× 13 1.9k
Karin Bink Germany 13 443 1.1× 197 0.6× 154 0.5× 138 0.5× 105 0.4× 25 1.2k
Uwe Kordes Germany 21 1.1k 2.7× 197 0.6× 585 1.8× 356 1.4× 322 1.3× 58 1.6k
Kirsten van Lom Netherlands 25 539 1.4× 153 0.5× 205 0.6× 427 1.6× 134 0.5× 47 1.5k
Markus Kreuz Germany 19 392 1.0× 134 0.4× 601 1.9× 210 0.8× 125 0.5× 50 1.0k
Jacques Vargaftig France 12 309 0.8× 188 0.6× 202 0.6× 249 1.0× 98 0.4× 23 887
Richard J. Dahl United States 12 280 0.7× 122 0.4× 113 0.4× 217 0.8× 155 0.6× 16 762
Véronique Laithier France 12 267 0.7× 271 0.8× 41 0.1× 184 0.7× 138 0.5× 27 1.1k
Purificación García‐Miguel Spain 18 424 1.1× 123 0.4× 59 0.2× 61 0.2× 188 0.7× 36 936
Josette Derré France 20 662 1.7× 71 0.2× 169 0.5× 94 0.4× 154 0.6× 47 1.4k

Countries citing papers authored by Marc Shuman

Since Specialization
Citations

This map shows the geographic impact of Marc Shuman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Shuman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Shuman more than expected).

Fields of papers citing papers by Marc Shuman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Shuman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Shuman. The network helps show where Marc Shuman may publish in the future.

Co-authorship network of co-authors of Marc Shuman

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Shuman. A scholar is included among the top collaborators of Marc Shuman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Shuman. Marc Shuman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raveh, Yehuda, Vadim Shatz, Marc Shuman, et al.. (2022). Multivisceral Transplant in a Patient With Portopulmonary Hypertension: A Case Report. Transplantation Proceedings. 54(6). 1664–1670. 1 indexed citations
2.
Zabor, Emily C., Yuelin Li, Marc Shuman, et al.. (2012). Initial Reactions to Tobacco Use and Risk of Future Regular Use. Nicotine & Tobacco Research. 15(2). 509–517. 16 indexed citations
3.
Huang, Vera, Robert F. Place, Victoria Portnoy, et al.. (2011). Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Research. 40(4). 1695–1707. 236 indexed citations
4.
So, Alex Yick‐Lun, Erwin de la Fuente-Ortega, Peter Walter, Marc Shuman, & Sebastián Bernales. (2009). The unfolded protein response during prostate cancer development. Cancer and Metastasis Reviews. 28(1-2). 219–223. 52 indexed citations
5.
Rubenstein, James L., Jane Fridlyand, Lauren E. Abrey, et al.. (2007). Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma. Journal of Clinical Oncology. 25(11). 1350–1356. 243 indexed citations
7.
Chan, June M., Angela M. Feraco, Marc Shuman, & Sonia Hernández–Dı́az. (2006). The Epidemiology of Prostate Cancer—with a Focus on Nonsteroidal Anti-inflammatory Drugs. Hematology/Oncology Clinics of North America. 20(4). 797–809. 8 indexed citations
8.
Rubenstein, James L., Jane Fridlyand, Arthur Shen, et al.. (2006). Gene expression and angiotropism in primary CNS lymphoma. Blood. 107(9). 3716–3723. 150 indexed citations
9.
Rubenstein, James L., Arthur Shen, Jane Fridlyand, et al.. (2004). Additive effect of the combination of 5-aza-2’-deoxycytidine and valproic acid in leukemia cell systems. 64. 1022–1022. 5 indexed citations
10.
Rubenstein, James L., Arthur Shen, Lauren E. Abrey, et al.. (2004). Results from a phase I study of intraventricular administration of rituximab in patients with recurrent lymphomatous meningitis. Journal of Clinical Oncology. 22(14_suppl). 6593–6593. 5 indexed citations
11.
Tindall, Donald J., Andrew M. Hruszkewycz, Suresh Mohla, et al.. (2004). Symposium on Androgen Action in Prostate Cancer. Cancer Research. 64(19). 7178–7180. 8 indexed citations
12.
Rubenstein, James L., Nancy J. Fischbein, Ken Aldape, Eric Burton, & Marc Shuman. (2002). Hemorrhage and VEGF Expression in a Case of Primary CNS Lymphoma. Journal of Neuro-Oncology. 58(1). 53–56. 34 indexed citations
13.
Elfman, Fred, Robert Bok, Marion Conn, Marc Shuman, & Gerald R. Cunha. (2001). Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate. Differentiation. 69(2-3). 108–120. 5 indexed citations
14.
Shuman, Marc & Ronald K. Wright. (1999). Evaluation of Clinician Accuracy in Describing Gunshot Wound Injuries. Journal of Forensic Sciences. 44(2). 339–342. 12 indexed citations
17.
Krill, Diane, Marc Shuman, Melissa Thompson, Michael J. Becich, & Stephen C. Strom. (1997). A simple method for the isolation and culture of epithelial and stromal cells from benign and neoplastic prostates. Urology. 49(6). 981–988. 38 indexed citations
18.
Ingerslev, J., D A Gastineau, Gerald Gilchrist, et al.. (1996). Major Surgery in Haemophilic Patients with Inhibitors Using Recombinant Factor VIla. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 1). 118–123. 109 indexed citations
19.
Kirn, David H., et al.. (1995). Serum Ferritin Levels Correlate with Disease Activity in Patients with AIDS and Disseminated Histoplasmosis. Clinical Infectious Diseases. 21(4). 1048–1049. 21 indexed citations
20.
Fenton, John W., Marc Shuman, & Daniel A. Walz. (1986). Introduction. Annals of the New York Academy of Sciences. 485(1). 2–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026